Dark Matter Blog

JULY 16, 2021

The only subject in school that held my interest was biology. As soon as I learned about DNA and RNA, I wanted to be a molecular biologist. I wanted to use molecular biology to create drugs. My last stop at Arrakis Therapeutics is with a company targeting RNA with small molecules.

Small Molecule 52

Small Molecule RNA Clinical Trials DNA 52

BMG Labtech

FEBRUARY 24, 2025

Detecting nitrated tyrosine residues in these assays presents challenges due to the complexities in accurately quantifying and identifying these specific modifications in proteins. In the highlighted study, the CLARIOstar Plus was used to detect peroxynitrite during phagocytosis with a small molecule sensor. The assay (Fig.

Small Molecule 52

Small Molecule Disease Licensing Licensing 52

Codon

MAY 29, 2025

While small-molecule drugs continue to play a critical role in modern medicine, we are witnessing a shift toward the increasing development of amino acid-based therapeutics. Toxic peptides and proteins, particularly from the venoms of animals, are predicted to be a major source of next-generation peptide and protein-based drugs.

Drugs 105

Drugs DNA RNA Laboratories 105